SUPTAVUMAB
UNII A0ZE931055

Substance Identification & Data

This profile provides standardized clinical and technical data for Suptavumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A0ZE931055.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1629615-23-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A0ZE931055

CAS Registry Number

1629615-23-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SUPTAVUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152476

National Cancer Institute reference terminology for clinical and research data.

INN ID

10303

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-88

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Suptavumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUPTAVUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN) (HUMAN MONOCLONAL REGN2222 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2222 .KAPPA.-CHAIN, DIMER

SUPTAVUMAB [INN]

SUPTAVUMAB [USAN]

SUPTAVUMAB [WHO-DD]